Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 20 Issue: 3, March 2020



Meet Our Executive Guest Editor free to download

Volume:20   Issue: 3
Pp: 167-167
H. Konig
DOI: 10.2174/156800962003200207113653
Published on: 06 February, 2020



Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects open access plus

Volume:20   Issue: 3
Pp: 168-186
Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Syed Nudrat Nawaid Shah and Muzna Shah
DOI: 10.2174/1568009620666191220151856
Published on: 20 December, 2019




The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma

Volume:20   Issue: 3
Pp: 187-196
Chu Xin Ng and Sau Har Lee*
DOI: 10.2174/1568009619666191111141032
Published on: 11 November, 2019



PPARγ Agonists in Combination Cancer Therapies

Volume:20   Issue: 3
Pp: 197-215
Piotr Mrowka and Eliza Glodkowska-Mrowka*
DOI: 10.2174/1568009619666191209102015
Published on: 08 December, 2019




Effects of Intermittent Hypoxia on Expression of Glucose Metabolism Genes in MCF7 Breast Cancer Cell Line

Volume:20   Issue: 3
Pp: 216-222
Yazun Jarrar, Malek Zihlif*, Abdel Qader Al Bawab and Ahmad Sharab
DOI: 10.2174/1568009619666191116095847
Published on: 15 November, 2019




Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

Volume:20   Issue: 3
Pp: 223-238
Wioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, Natalia Siwecka, Adam Dziki, Łukasz Dziki, J. Alan Diehl and Ireneusz Majsterek*
DOI: 10.2174/1568009620666200106114826
Published on: 05 January, 2020